Welcome to our dedicated page for Appyea news (Ticker: APYP), a resource for investors and traders seeking the latest updates and insights on Appyea stock.
AppYea, Inc. (OTCQB: APYP) is a public technology company developing blockchain-based trust infrastructure for regulated, outcome-driven markets. Its news flow documents a strategic pivot around the Techlott platform, a decentralized lottery and gaming engine designed for transparency, verifiable randomness, and real-time outcome verification.
News items for APYP frequently cover corporate transformation milestones, including the acquisition of Techlott’s blockchain technology, integration of that platform into AppYea’s operations, and leadership appointments that align technical ownership with governance. Press releases detail the company’s focus on B2G/B2B deployments for governments, regulators, and institutional operators in lottery, gaming, and prediction markets.
Investors following APYP news can expect updates on technology development and readiness, such as multi-game adaptation of the Techlott engine, multi-chain support, and audit-focused features like on-chain receipts and verifiable randomness workflows. The company also reports on its evaluation of entry into regulated prediction markets and potential introduction of a Techlott network token for system-level functions, while emphasizing regulatory considerations.
Another recurring theme in AppYea’s news is its capital markets and governance roadmap, including internal reviews related to a potential uplisting to a U.S. national securities exchange and a planned rebranding and name change to Mellatrix Inc., subject to approvals. Announcements also highlight institutional engagement, such as advanced-stage discussions with operators and regulators and a Letter of Intent to deploy Techlott infrastructure in a regulated digital gaming and prize-draw environment in The Republic of The Gambia.
This APYP news page aggregates these disclosures so readers can track AppYea’s progress in technology integration, commercial execution, regulatory engagement, and corporate strategy over time.
AppYea Inc. (OTCQB:APYP) has announced a strategic acquisition of Techlott Ltd.'s blockchain-based lottery and gaming platform, marking a significant business pivot. The platform features on-chain draw logic, verifiable randomness, and automated workflows, projecting substantial operational cost reductions for partners.
The global lottery market is valued at $353.29B (2024) and expected to reach $483.93B by 2030, with only 16% of activity currently online. The acquisition positions AppYea to capture this digital transformation opportunity. As part of the deal, Techlott becomes a significant shareholder with board representation, and AppYea plans to pursue an uplisting to a major US exchange.
AppYea (OTCQB: APYP) has announced significant leadership changes with the appointment of Yakir Abadi as CEO and Director, alongside Eldar Edmond Grady as Executive Chairman of the Board. Abadi, recognized as one of Israel's leading fintech and blockchain entrepreneurs, brings extensive experience in digital banking, blockchain solutions, and cryptocurrency investments.
Grady joins as Executive Chairman, bringing valuable experience as owner of an international holding company that consults for NASDAQ-listed corporations and operates a leading PPLI wealth management agency. Former CEO Boris Molchadsky will remain as a director, expressing confidence in the new leadership team's ability to drive shareholder value.
AppYea Inc. (OTCQB: APYP) has launched AppySleep, an innovative wearable solution to address snoring and monitor sleep apnea. The device consists of a smart biofeedback-based wristband that connects to an app on iPhone or Android. It detects snoring and activates gentle vibrations to prompt users to change their sleeping position.
Key features include:
- AI-powered customization of snoring treatment
- Detection of irregular breathing patterns
- Personal cloud access for sleep history and statistics
- Introductory price of $149
AppYea is also developing AppySleep LAB, a touchless app for diagnosing sleep apnea without overnight lab stays. The company plans to pre-submit an FDA request for AppySleep LAB in H1 2025. Market projections indicate significant growth potential in the sleep tech and anti-snoring treatment sectors.
AppYea's Chairman Bary Molchadsky has converted approximately $140,000 of his debt into company warrants, with a strike price of $0.07 per share, reflecting a 250% premium over the current market price. This move demonstrates his confidence in the company's prospects. AppYea has recently started commercial deliveries of its AppySleep product in the U.S. and launched a new direct sales website and an Amazon store. The AppySleep wristband, a smart wearable for monitoring and treating sleep apnea and snoring, integrates with a smartphone app to improve sleep quality.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.